The MGA Machine: How Octave Specialty is Using ‘Hammurabi’ AI to Rewrite the Insurance Playbook
1. The Hook: A Milestone in Transformation
Q4 2025 was the moment Octave Specialty Group stripped off the training wheels of its legacy structure. For the first time, the company reported as a fully standalone specialty insurance platform, concluding a multi-year pivot that serves as a masterclass in navigating the “incumbent’s dilemma.” In an industry where complex firms are often paralyzed by the friction between ossified legacy tech and the need for high-velocity underwriting, Octave has successfully decoupled, repositioning itself as an agile, MGA-centric powerhouse.
This transition isn’t just a corporate rebrand; it is a structural overhaul designed to solve the fundamental problem of modern insurance: how to scale specialized risk without bloating the balance sheet. This post dives into the surprising shifts revealed in their latest earnings call—from AI-driven pricing to a built-in earnings engine that most analysts have yet to fully model.
2. The “Hammurabi” Moment: AI Moves from Hype to High-Speed Execution
While most of the insurance sector is still trapped in “pilot purgatory” with Artificial Intelligence, Octave has deployed a proprietary platform, “Hammurabi,” that is already moving the needle. Specifically targeted at the medical stop-loss (ESL) business, Hammurabi solves the high-friction problem of manual risk assessment in a volatile segment.
By replacing labor-intensive underwriting with “near instant” risk prediction, Octave has achieved a level of operational velocity that traditional carriers simply cannot match. This isn’t just about cutting headcount; it’s about pricing accuracy. In a market where a few basis points of mispricing can erase a year’s profit, Hammurabi provides a structural edge that allows Octave to scale its ESL business while competitors are still stuck in the data-entry phase.
“Hammurabi replaces traditional labor-intensive processes with near instant risk prediction and pricing accuracy… we believe Hammurabi is a genuine competitive differentiator.” — Claude LeBlanc, President and CEO
3. Embedded Growth: Why the Best is Yet to Come
The most compelling part of the Octave narrative is the “youth” of its portfolio. Of its 22 Managing General Agents (MGAs), nine were launched between 2024 and 2025. This means that 40% of the portfolio is still in an early-stage growth phase—a “stable” of future earnings that have already incurred their startup costs but have yet to reach full harvesting maturity.
The proof of this “MGA engine” is in the numbers: Octave Ventures, the company’s incubator arm, saw organic revenue growth skyrocket to 47% in 2025, up from 18% in 2024. The recent launch of 1889 Specialty, focusing on the SME financial institutions market, demonstrates the company’s ability to rapidly stand up businesses in high-margin niches. For investors, this represents “embedded growth”—revenue that is already locked in but will only become visible as these entities scale over the next 2–4 years.
4. The ArmadaCare Acquisition: Chasing 40% Margins
The Q4 report solidified the strategic importance of the ArmadaCare acquisition, a move designed to insulate Octave from the softening P&C market. With property rates seeing 5% to 10% reductions in certain programs, Octave is aggressively pivoting toward the Accident & Health (A&H) sector, which is less correlated with the general commercial cycle.
ArmadaCare delivers “sticky” recurring revenue with EBITDA margins exceeding 40%. By 2026, A&H is expected to account for roughly a quarter of Octave’s distribution business. This shift is a deliberate hedge: while excess casualty lines are seeing double-digit rate increases, the stability of A&H revenue provides a durable floor for the company’s earnings profile.
5. Geographic Arbitrage: The Tale of Two Markets (London vs. U.S.)
Octave’s footprint across London, Bermuda, and the U.S. is not merely a geographic convenience—it is a tool for capital arbitrage. The company’s portfolio is meticulously diversified across nine P&C segments, with a strategic split of 30% casualty and 42% non-CAT property.
The earnings call highlighted a dual-track strategy:
- London/Bermuda MGAs: These entities reach profitability faster and navigate pricing cycles with higher velocity, allowing Octave to deploy capital “opportunistically” when markets harden.
- U.S. MGAs: These provide the ballast, offering rate stability and more predictable underwriting conditions that support consistent long-term margin management.
This geographic spread allows Octave to pivot resources toward wherever the pricing is most favorable, whether that is chasing double-digit increases in London-based excess casualty or maintaining steady margins in U.S. SME lines.
6. The Minority Interest Buy-In: A Built-In Earnings Engine
Perhaps the most sophisticated lever in Octave’s strategy is its systematic “minority interest buy-in.” For many of its MGAs, Octave holds a predetermined schedule to acquire larger stakes as the businesses perform. This creates a “low-risk M&A” environment: instead of buying unknown entities, Octave “doubles down” on the winners already operating within its ecosystem.
This mechanism allows the company to scale shareholder earnings without the integration risks of traditional acquisitions. It is a predictable, contractual pathway to growth that converts MGA success directly into bottom-line EPS.
“Our expectations… is that NCI buy-in this year will be less than $50 million. And so funding for that will come from cash… and some marginal additional borrowing.” — David Trick, Chief Financial Officer
Conclusion: The 2026 Outlook
As we look toward 2026, Octave’s trajectory is clear. The company has guided for at least 20% organic revenue growth and an expected adjusted net income of approximately $0.50 per share. As the “investment drag” from its 2024–2025 startups fades, the inherent operating leverage of the platform is poised to accelerate.
As the industry moves into a tech-driven era, a fundamental question remains: Does the “MGA-first” model, powered by proprietary AI like Hammurabi, represent the permanent blueprint for the next generation of insurance giants?
Octave Specialty Group is betting its entire future that the answer is yes.
Briefing Document: Octave Specialty Group Q4 2025 Earnings Analysis
Executive Summary
Octave Specialty Group’s fourth quarter 2025 results mark its first full period operating as a standalone specialty insurance platform. This milestone follows a multi-year strategic transformation aimed at creating a scalable, data-driven infrastructure. Despite a reported net loss of $30 million for the quarter—largely driven by one-time transition costs, the ArmadaCare acquisition, and the exit from financial guarantee business—the company demonstrated significant growth in its core insurance distribution segment.
Critical Takeaways:
- Rapid Distribution Growth: Insurance distribution revenue increased by 65% over 2024, supported by 14% organic growth.
- MGA Maturation: Over 40% of the company’s 22 Managing General Agents (MGAs) are in early-growth stages, representing a “stable” of future earnings potential as they scale over the next two to four years.
- Technological Differentiation: The launch of “Hammurabi,” a proprietary AI platform for medical stop-loss, is driving record results in the ESL business by enabling near-instant risk pricing.
- 2026 Profitability Guidance: Management expects to generate an adjusted net income of approximately $0.50 per share in 2026, with insurance distribution organic revenue growth of at least 20%.
- Strategic Acquisition: The integration of ArmadaCare is ahead of schedule, providing high-margin (40%+) recurring revenue less correlated to the Property and Casualty (P&C) cycle.
——————————————————————————–
Strategic Foundation and Platform Evolution
Octave has transitioned into a specialized insurance distribution and underwriting platform comprised of two primary segments: the Insurance Distribution segment (Octave Partners and Octave Ventures) and the Specialty Insurance segment (Everspan).
The MGA Ecosystem
The company’s model relies on a “hub-and-spoke” approach where a centralized operating model supports entrepreneurial underwriting talent.
- Portfolio Composition: Currently operates 22 MGAs.
- Geographic Split: 13 MGAs are based in the U.S., while 9 are located in London and Bermuda.
- Market Dynamics: Management noted that Lloyd’s market MGAs (London/Bermuda) typically reach profitability and move through pricing cycles faster, while U.S. MGAs provide greater rate stability and predictable underwriting conditions.
Embedded Growth Drivers
A significant portion of Octave’s value proposition is tied to the “natural maturation curve” of its newer entities:
- Early-Stage Scaling: Nine MGAs were launched in 2024 and 2025.
- Minority Interest Buy-ins: Octave holds contractual rights to acquire minority interests in its MGAs over a predetermined schedule. This allows the company to systematically increase earnings attributable to shareholders as these MGAs become profitable.
- Pipeline: Octave Ventures (the incubator arm) continues to target two to four new MGA launches per year, with a current focus on U.S. Excess and Surplus (E&S) and Small to Medium Enterprise (SME) segments.
——————————————————————————–
Technological Integration and AI
A central pillar of Octave’s 2026 strategy is the unification of its operating infrastructure onto a single integrated data and technology architecture.
The Hammurabi Platform
The flagship of Octave’s AI initiative is “Hammurabi,” a proprietary tool currently deployed in the medical stop-loss (ESL) business.
- Functionality: Replaces labor-intensive traditional underwriting with near-instant risk prediction and pricing accuracy.
- Impact: Cited as a primary catalyst for record results in the ESL business following several challenging years.
- Future Utility: Management intends to expand Hammurabi’s capabilities to other business lines to improve risk selection and operational velocity across the platform.
——————————————————————————–
Segment Performance and Analysis
Insurance Distribution
This segment remains the primary engine of growth.
- Revenue Growth: Organic revenue growth for Octa Ventures rose from 18% in 2024 to 47% in 2025.
- Product Diversification: The portfolio is split between Specialty Accident & Health (A&H) (28%) and Specialty P&C (72%). The P&C portion is further divided into 30% casualty and 42% non-CAT-exposed property.
- ArmadaCare: This acquisition deepens Octave’s position in the A&H market. A&H is expected to account for 25% of the distribution business in 2026.
Specialty Insurance (Everspan)
Following a period of strategic repositioning and reserve strengthening in early 2025, Everspan has reached a point of “controlled growth.”
- Combined Ratio: Fell below 100% (to 99.4%) for the first time in 2025.
- Loss Ratios: The effective loss and LAE ratio (including sliding scale commissions) improved to 62.9% in Q4 2025, compared to 66.8% in Q4 2024.
- Focus: Everspan is primarily targeting the casualty markets, where pricing discipline remains stronger than in property markets.
——————————————————————————–
Financial Results and 2026 Guidance
Q4 2025 Financial Summary
| Metric | Q4 2025 | Q4 2024 |
| Net Loss to Shareholders | ($30 Million) | ($22 Million) |
| Adjusted EBITDA (Continuing Ops) | $1.4 Million | $0.5 Million |
| Distribution Adjusted EBITDA Margin | 15% | 12% |
| Everspan Effective Loss Ratio | 62.9% | 66.8% |
| Corporate G&A (Reported) | $25 Million | $14.6 Million |
Note on G&A: The spike in reported G&A was due to $7.8 million in acquisition/integration costs, $3.1 million in legacy impairments, and $7.6 million in restructuring initiatives.
2026 Outlook
Management provided specific targets for the upcoming fiscal year, reflecting confidence in the platform’s maturation.
| Segment / Metric | 2026 Target |
| Distribution Organic Revenue Growth | \ge 20% |
| Distribution Adjusted EBITDA | ~$40 Million |
| Everspan Gross Written Premium | ~$410 Million |
| Everspan Adjusted EBITDA | ~$7.5 Million |
| Corporate Adjusted Expenses | < $30 Million |
| Consolidated Adjusted Net Income | ~$0.50 per share |
——————————————————————————–
Market Environment and Pricing Trends
CEO Claude LeBlanc provided an incisive look at current market conditions across Octave’s three primary buckets:
- Non-CAT Property: Seeing rate reductions of 5% to 10% on some programs, though others remain stable.
- Casualty: Maintaining pricing discipline. Excess casualty lines are experiencing double-digit rate increases.
- Accident & Health (A&H): Experiencing very strong organic growth. Pricing increases are averaging between 10% and 12%, supplemented by significant volume growth from new product launches.
Key Management Quotes
“Our model has allowed us to attract and partner with top underwriting talent… The culture we have built is one of entrepreneurship, collaboration, specialization, and partnership.” — Claude LeBlanc, CEO
“Hammurabi replaces traditional labor-intensive processes with near instant risk prediction and pricing accuracy… we believe Hammurabi is a genuine competitive differentiator.” — Claude LeBlanc, CEO
“All but two [negative EBITDA entities] are anticipated to be breakeven or be profitable by the fourth quarter of 2026. This dynamic is characteristic of a component of our underlying growth engine.” — David Trick, CFO